Parish LC |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group. |
1993 |
Int. J. Dermatol. |
pmid:8340194
|
Monteforte JS and Wood CA |
Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8500477
|
Hakkarinen WD |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482929
|
Luger SW |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482930
|
Sedlmayr T et al. |
[Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk]. |
1993 |
Geburtshilfe Frauenheilkd |
pmid:8370491
|
Chien SM et al. |
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group. |
1993 |
Chest |
pmid:8449054
|
Ji B et al. |
Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. |
1993 |
J. Infect. Dis. |
pmid:8257487
|
Scaglione F et al. |
The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxy clarithromycin. |
1993 |
J. Antimicrob. Chemother. |
pmid:8262876
|
Guay DR and Craft JC |
Overview of the pharmacology of clarithromycin suspension in children and a comparison with that in adults. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295810
|
Watanabe Y et al. |
Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. |
1993 |
J. Antibiot. |
pmid:8501007
|
Roig J et al. |
Treatment of Legionnaires' disease. Current recommendations. |
1993 |
Drugs |
pmid:7691508
|
Chu SY et al. |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. |
1993 |
J Clin Pharmacol |
pmid:8331208
|
Graham DY et al. |
Clarithromycin for the eradication of Helicobacter pylori. |
1993 |
J. Clin. Gastroenterol. |
pmid:8331260
|
Esvant H et al. |
[Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. |
1993 |
Presse Med |
pmid:8337221
|
Lederer J et al. |
Clarithromycin treatment of posttraumatic Mycobacterium fortuitum wound infection. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8414785
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
Mazzei T et al. |
Chemistry and mode of action of macrolides. |
1993 |
J. Antimicrob. Chemother. |
pmid:7683018
|
Lazard T et al. |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684213
|
Emori M et al. |
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684214
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|
Watanabe Y et al. |
Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives. |
1993 |
J. Antibiot. |
pmid:8360112
|
Ruf B et al. |
Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients. |
1992 Sep-Oct |
Infection |
pmid:1428183
|
Friend DR |
Polyacrylate resin microcapsules for taste masking of antibiotics. |
1992 Oct-Dec |
J Microencapsul |
pmid:1403495
|
de Campora E et al. |
Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535578
|
Nilsen OG et al. |
Macrolide pharmacokinetics and dose scheduling of roxithromycin. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535579
|
Hoover WW et al. |
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin. |
1992 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:1533827
|
Chapelsky MC et al. |
Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers. |
1992 Jul-Aug |
Drug Saf |
pmid:1355971
|
Logan RP et al. |
Clarithromycin and omeprazole for Helicobacter pylori. |
1992 |
Lancet |
pmid:1353155
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Paulsen P et al. |
Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome. |
1992 |
Chemotherapy |
pmid:1324831
|
Heifets LB et al. |
Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1532486
|
Ruf B et al. |
Acquired resistance of MAI to clarithromycin. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1533999
|
Chonmaitree T et al. |
Effect of viral respiratory tract infection on outcome of acute otitis media. |
1992 |
J. Pediatr. |
pmid:1534364
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
Berk SL |
New macrolide antibiotics. |
1992 |
Ann. Intern. Med. |
pmid:1386966
|
Chu SY et al. |
Absolute bioavailability of clarithromycin after oral administration in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387301
|
Yajko DM et al. |
Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387302
|
de Lalla F et al. |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387303
|
Yajko DM |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? |
1992 |
Res. Microbiol. |
pmid:1455069
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Sturgill MG and Rapp RP |
Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles. |
1992 |
Ann Pharmacother |
pmid:1421677
|
Denny FW |
Current management of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453145
|
Schrock CG |
Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453146
|
Chaisson R |
Clarithromycin is effective against M. avium complex in AIDS. |
1992 |
Am Fam Physician |
pmid:1456199
|
Ji B et al. |
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482155
|
Rastogi N and Goh KS |
Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482156
|
Rastogi N et al. |
Activity of clarithromycin compared with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482157
|
Derouin F et al. |
Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482160
|
Takeda H et al. |
[A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa]. |
1992 |
Kansenshogaku Zasshi |
pmid:1363435
|